The World Health Organization (WHO) on Tuesday (May 26) said that it will conduct a swift review of data on anti-malarial drug hydroxychloroquine by mid-June after the global health body suspended the use of HCQ in a trial on the treatment of coronavirus COVID-19 patients due to safety concerns.
from Zee News :World https://ift.tt/2M2VajS
Tuesday, 26 May 2020
Related Posts:
Pakistani news media refers to terrorist behind Pulwama attack as 'freedom fighter'
Pulwama suicide attack: Terrorist for entire world, 'freedom fighter' for Pakistani media
Five killed as gunman opens fire at Illinois warehouse
In aftermath of Pulwama attack, WION withdraws invite to Pakistani speakers for Global Summit
0 comments: